Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply.

Lancet

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(24)01049-3DOI Listing

Publication Analysis

Top Keywords

sacituzumab govitecan
4
govitecan metastatic
4
metastatic breast
4
breast cancer
4
cancer tropics-02
4
tropics-02 trial
4
trial authors'
4
authors' reply
4
sacituzumab
1
metastatic
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!